trial · primary record
Cyclophosphamide
Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 110 |
| Primary completion | 2028-06-29 |
| Primary endpoint | Response rate |
| Registry ID | NCT03190941 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:33.717Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03190941
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cyclophosphamide · approval
- Cyclophosphamide · compound